此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Analgesic Efficiency of SIPSPB vs ICNB in VATS Surgery

2026年8月24日 更新者:Abdullah Bozkurt、Kocaeli City Hospital

Comparison Of The Analgesic Effectiveness Of Ultrasonography-Guided Serratus Posterıor Superior Intercostal Plane (SPSIP) Block And Intercostal Nerve (ICN) Block In Video-Assisted Thoracoscopic Surgery Patients

This study aims to evaluate the effectiveness of Serratus Posterior Superior Intercostal Plane (SPSIP) block compared to Intercostal Nerve (ICN) block in terms of postoperative pain control, reduction of opioid analgesic consumption, minimization of postoperative respiratory complications, and increase patient satisfaction (using a 5-point Likert scale) in patients undergoing video-assisted thoracoscopic surgery (VATS).

研究概览

详细说明

In this prospective observational study, patients included in the study will receive Serratus Posterior Superior Intercostal Plane (SPSIP) block and Intercostal Nerve (ICN) block for postoperative analgesia at the end of surgery. The SPSIP block will be performed by the anesthesiologist under ultrasound guidance immediately after skin closure and before extubation, while the ICN block will be performed by the surgeon under direct vision immediately before skin closure.

At the end of surgery, patients will receive 1000 mg paracetamol and 50 mg dexketoprofen during skin closure. Upon arrival at the recovery room, each patient will be connected to a patient-controlled analgesia (PCA) pump containing tramadol. At postoperative reassessment, patients with a Numerical Pain Rating Scale (NPRS) score greater than 4 despite PCA use will receive a rescue analgesic dose of 50 mg dexketoprofen.

Postoperative pain intensity will be assessed using the NPRS (Numerical Pain Rating Scale) at 1, 4, 6, 12, 18, and 24 hours postoperatively, both at rest and during coughing. Total opioid consumption, rescue analgesic use, and postoperative complications will be recorded.

Patients will be informed about their level of surgical satisfaction 24 hours after surgery, and this information will be recorded.

研究类型

观察性的

注册 (实际的)

82

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

概率样本

研究人群

Patients who will undergo elective VATS surgery in the thoracic surgery operating room of Kocaeli City Hospital

描述

Inclusion Criteria:

  • Aged 18-80 years,
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Patients who have provided informed consent to participate in the study

Exclusion Criteria:

  • Patients who refuse to participate in the study by not signing the informed consent
  • Patients classified as ASA > 3, according to the system established by the American Society of Anesthesiologists
  • Patients unable to understand the use of the NPR Scale or the PCA device that will be used for postoperative analgesia
  • Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
  • Patients with allergies to analgesic and/or anesthetic drugs
  • Infection at the block injection site
  • Patients whose surgical procedure is intraoperatively converted to an open pulmonary resection

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Group SPSIP Block
In patients meeting the inclusion criteria for the study, an ultrasound-guided interfacial plane block is applied between the posterior superior serratus muscle and the underlying ribs in patients undergoing SPSIP block after VATS.
Group ICN Block
Patients meeting the inclusion criteria for the study who will undergo intercostal nerve block after VATS will have a total of 10 ml of 0.5% bupivacaine applied to two segments (upper and lower segments of the incision line) under direct vision by the surgeon while the patient is in the lateral decubitus position at the end of the operation and immediately before skin closure.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Postoperative pain intensity
大体时间:24 hours after the end of surgery
In both study groups, postoperative pain intensity at rest and with coughing was measured using the Numerical Pain Rating Scale (NPRS), a numerical scale ranging from 0 to 10 (0 meaning no pain, 10 meaning the most severe pain imaginable).
24 hours after the end of surgery

次要结果测量

结果测量
措施说明
大体时间
患者满意度评分
大体时间:术后第24小时
使用5点李克特量表进行评估(1=非常不满意,5=非常满意)
术后第24小时
Total opioid drug consumption
大体时间:24 hours after the end of surgery
The total amount of opioid doses administered via a Patient Controlled Analgesia (PCA) device in the first 24 hours after surgery
24 hours after the end of surgery
Consumption of rescue analgesics
大体时间:24 hours after the end of surgery
The total dose of dexketoprofen required by the patient during each specified time interval in the first 24 hours after surgery.
24 hours after the end of surgery
Postoperative Complications
大体时间:24 hours after the end of surgery
Postoperative complications such as nausea, vomiting or other adverse events will be recorded
24 hours after the end of surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Ayşe Z Turan Cıvraz, Assoc. Prof.、Kocaeli City Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年5月18日

初级完成 (实际的)

2026年8月1日

研究完成 (实际的)

2026年8月5日

研究注册日期

首次提交

2026年5月5日

首先提交符合 QC 标准的

2026年5月5日

首次发布 (实际的)

2026年5月11日

研究记录更新

最后更新发布 (实际的)

2026年8月26日

上次提交的符合 QC 标准的更新

2026年8月24日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • 250125

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅